References
- Elliott K J. Other neurologic complications of herpes zoster and their management. Ann Neurol 1994; 35: S57–S61, Suppl
- Nurmikko T, Bowsher D. Somatosensory findings in postherpetic neuralgia. J Neurol Neurosurg Psychiatry 1990; 53: 135–141
- Crooks R J, Jones D A, Fiddian A P. Zoster-associated chronic pain: An overview of clinical trials with acyclovir. Scand J Infect 1991, Suppl 80: 62–68
- Wood M J, Kay R, Dworkin R H, Soong S-J. Whidey Oral acyclovir accelerates pain resolution in herpes zoster: A meta-analysis of placebo-controlled trials. Clin Infect Dis 1996; 22: 341–347
- Esmann V, Geil J P, Krcons S, et al. Prednisolone does not prevent post-herpetic neuralgia. Lancet 1987; 2: 127–129
- Watson C PN, Watt V R, Chipman M, Birkoff N, Evans R J. The prognosis with postherpetic neuralgia. Pain 1991; 46: 195–199
- Rowbotham M C, Davies P S, Fields H L. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol 1995; 37: 246–253
- Max M B. Treatment of post-herpetic neuralgia: Antidepressants. Ann Neurol 1994; 35: 550–553
- Rowbotham M C, Miller K V, Davies P, et al. Topical lidocaine for postherpetic neuralgia pain: Results of a double-blind, vehicle-controlled trial. Neurology 1992; 42: 390
- Elliott K J, Brodsky M, Hynansky A, Foley K M, Inturrisi C E. Dextromethorphan suppresses both formalin-induced nociceptive behavior and the formalin-induced increase in spinal cord c-fos mRNA. Pain 1995; 61: 401–409
- Eide P K, Forum E, Stubhaug A, et al. Relief of postherpetic neuralgia with the N-methyl-D-aspartic acid receptor antagonist ketamine: A double-blind, cross-over comparison with morphine and placebo. Pain 1994; 58: 347–354